ZA761476B - Cefazolin suspension for parenteral administration - Google Patents
Cefazolin suspension for parenteral administrationInfo
- Publication number
- ZA761476B ZA761476B ZA761476A ZA761476A ZA761476B ZA 761476 B ZA761476 B ZA 761476B ZA 761476 A ZA761476 A ZA 761476A ZA 761476 A ZA761476 A ZA 761476A ZA 761476 B ZA761476 B ZA 761476B
- Authority
- ZA
- South Africa
- Prior art keywords
- cefazolin
- suspension
- parenteral administration
- parenteral
- administration
- Prior art date
Links
- MLYYVTUWGNIJIB-BXKDBHETSA-N cefazolin Chemical compound S1C(C)=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 MLYYVTUWGNIJIB-BXKDBHETSA-N 0.000 title 1
- 229960001139 cefazolin Drugs 0.000 title 1
- 238000007911 parenteral administration Methods 0.000 title 1
- 239000000725 suspension Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/573,283 US4029782A (en) | 1975-04-28 | 1975-04-28 | Cefazolin suspension for parenteral administration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA761476B true ZA761476B (en) | 1977-10-26 |
Family
ID=24291351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA761476A ZA761476B (en) | 1975-04-28 | 1976-03-10 | Cefazolin suspension for parenteral administration |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4029782A (https=) |
| JP (1) | JPS51130522A (https=) |
| AU (1) | AU505940B2 (https=) |
| BE (1) | BE841157A (https=) |
| DE (1) | DE2618422A1 (https=) |
| FR (1) | FR2309211A1 (https=) |
| GB (1) | GB1546479A (https=) |
| ZA (1) | ZA761476B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4344934A (en) * | 1978-11-20 | 1982-08-17 | American Home Products Corporation | Therapeutic compositions with enhanced bioavailability |
| GB8322364D0 (en) * | 1983-08-19 | 1983-09-21 | May & Baker Ltd | Compositions of matter |
| US6660049B1 (en) | 1996-07-31 | 2003-12-09 | Natural Soda Aala, Inc. | Process for control of crystallization of inorganics from aqueous solutions |
| US6495164B1 (en) * | 2000-05-25 | 2002-12-17 | Alkermes Controlled Therapeutics, Inc. I | Preparation of injectable suspensions having improved injectability |
| RU2310450C2 (ru) * | 2002-10-25 | 2007-11-20 | Пфайзер Продактс Инк. | Новые депо-препараты для инъекций |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3297692A (en) * | 1961-04-03 | 1967-01-10 | Lilly Co Eli | 7-alkylmercaptoacetamidocephalosporanic acid |
| GB1051746A (https=) * | 1961-12-22 | |||
| US3293133A (en) * | 1963-04-24 | 1966-12-20 | Squibb & Sons Inc | Method of imparting color to pharmaceutical solutions |
| CH557381A (de) * | 1967-04-15 | 1974-12-31 | Fujisawa Pharmaceutical Co | Verfahren zur herstellung von (delta)3-cephemverbindungen. |
| GB1244501A (en) * | 1968-03-09 | 1971-09-02 | Aspro Nicholas Ltd | Heterocyclic amines |
| US3678163A (en) * | 1969-06-02 | 1972-07-18 | Merck & Co Inc | Stabilized aqueous suspension of calcium (-) (cis-1,2-epoxypropyl)-phosphonate |
| US3897423A (en) * | 1973-03-05 | 1975-07-29 | Squibb & Sons Inc | Amino substituted acylthio cephalosporins |
-
1975
- 1975-04-28 US US05/573,283 patent/US4029782A/en not_active Expired - Lifetime
-
1976
- 1976-03-10 ZA ZA761476A patent/ZA761476B/xx unknown
- 1976-03-11 AU AU11868/76A patent/AU505940B2/en not_active Expired
- 1976-04-06 JP JP51039139A patent/JPS51130522A/ja active Pending
- 1976-04-23 GB GB16489/76A patent/GB1546479A/en not_active Expired
- 1976-04-27 DE DE19762618422 patent/DE2618422A1/de not_active Withdrawn
- 1976-04-27 BE BE1007345A patent/BE841157A/xx unknown
- 1976-04-28 FR FR7612617A patent/FR2309211A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| BE841157A (fr) | 1976-10-27 |
| AU1186876A (en) | 1977-09-15 |
| DE2618422A1 (de) | 1976-11-11 |
| FR2309211B1 (https=) | 1979-03-23 |
| JPS51130522A (en) | 1976-11-12 |
| GB1546479A (en) | 1979-05-23 |
| US4029782A (en) | 1977-06-14 |
| FR2309211A1 (fr) | 1976-11-26 |
| AU505940B2 (en) | 1979-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT65863A (en) | Capsules | |
| JPS5214503A (en) | Phosphorusscontaining tantalum | |
| JPS5254278A (en) | Solid stabilizer | |
| GB1546958A (en) | Bottom bracket assemblies for bicvcles | |
| CS191969B2 (en) | Vertical centrifuge | |
| GB1539261A (en) | Cover-sealing arrangement | |
| AU2015876A (en) | Parenteral administration set | |
| JPS5210300A (en) | *nichinichika* alkaroid derivative | |
| HK35282A (en) | Rifamycin derivatives | |
| GB1541650A (en) | Synchronising arrangement | |
| JPS51147306A (en) | Stabilizer | |
| JPS51129028A (en) | Suspension system | |
| GB1486118A (en) | Rifamycin derivatives | |
| JPS5251619A (en) | Suspension assembly | |
| ZA761476B (en) | Cefazolin suspension for parenteral administration | |
| GB1543043A (en) | Racking mechanisms | |
| GB1546943A (en) | Suspension system | |
| CH607921A5 (en) | Infusion/flushing arrangement | |
| GB1517385A (en) | Phenothiazine derivatives | |
| PH13321A (en) | Cephalosporin derivative | |
| JPS5180613A (en) | Kyodo jinseinosuguretatanzohinnoseizohoho | |
| JPS5267878A (en) | Vertical type filterrhydroextractor | |
| JPS529537A (en) | Hanger | |
| JPS5276309A (en) | Tublar refractories | |
| JPS51112676A (en) | Hanger |